1 We have assessed the potential of several m-opioid receptor antagonists to elicit a response in the guinea-pig isolated ileum in the presence of, and following overnight exposure to, morphine. 2 Naloxone, D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH 2 (CTOP), (7)-5,9a-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorphan (MR2266), but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH 2 (CTAP), produced a transient inhibition of electrically-evoked contractions of the guinea-pig ileum. The eect of 1 mM CTOP, but not that to MR2266, was inhibited by 1 mM somatostatin. 3 Naloxone (0.3 mM), CTOP (3 mM), CTAP (3 mM) and MR2266 (0.3 mM) antagonized the inhibitory eect of morphine on electrically-evoked contractions of the guinea-pig to a similar degree and, following 60 min exposure to morphine, produced non-sustained contractions. The response to 3 mM CTOP was signi®cantly smaller than that to 3 mM CTAP. None of the antagonists produced a response in the absence of morphine. 4 Following overnight exposure of the ileum to 0.3 mM morphine (48C), and repeated washing to remove the agonist, all four antagonists elicited non-sustained contractions. However, the responses to 3 mM CTOP and 0.3 mM MR2266 were signi®cantly smaller than those elicited by 0.3 mM naloxone and 3 mM CTAP. Somatostatin (1 mM) signi®cantly reduced naloxone-induced contractions, but not those to CTAP. 5 While all four m-opioid antagonists elicited contractions in the presence of, and following prolonged exposure to, morphine, dierences between them were noted which may be a consequence of non-opioid actions.
Introduction
Evidence is accumulating that many receptor antagonists not only occupy the active sites to block responses to agonists, but under certain conditions have the potential to elicit biological responses functionally opposite to that of agonists, so-called inverse agonism' at constitutively-activated receptors (Milligan et al., 1995; Kenakin 1999) . In the majority of instances, however, the eects of putative inverse agonists have been reported in cultured cells with the pharmacological signi®cance of the ®ndings unclear.
For example, acute exposure of SH-SY5Y cells to the mopioid receptor agonist morphine caused a reduction in forskolin-stimulated cyclic AMP which was abolished by the antagonist naloxone (Yu & Sadee, 1988; Yu et al., 1990) . Naloxone alone produced very little eect on cyclic AMP levels. However, following prolonged exposure to morphine and extensive washing, resting level of cyclic AMP was elevated and, under this condition, many m-opioid receptor antagonists, including naloxone, caused a further increase in the level of the cyclic nucleotide (Wang et al., 1994) . In marked contrast, the somatostatin derivatives D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH 2 (CTOP) and D-Phe-Cys-Tyr-DTrp-Arg-Thr-Pen-Thr-NH 2 (CTAP), which are recognized as potent antagonists of m-opioid receptors (Hawkins et al., 1989; Kramer et al., 1989) , failed to in¯uence cyclic AMP levels but abolished both the stimulatory eect of naloxone and the inhibitory response to morphine (Wang et al., 1994) . These authors concluded that prolonged exposure of SH-SY5Y cells to morphine induced a constitutively activated state of the m-opioid receptor, at which naloxone then exhibited inverse agonist activity while CTOP and CTAP behaved as conventional`neutral' antagonists. Qualitatively similar responses to naloxone have also been reported in HEK 293 cells previously exposed to morphine (Wang et al., 1999) .
With respect to the action of naloxone, there are interesting parallels with observations in a physiologically-intact tissue, the guinea-pig isolated ileum. It is well documented that while naloxone per se exerts little eect on electrically-evoked contractions in this preparation, the reversal of morphineinduced inhibition of these responses is associated with the appearance of a`withdrawal' contraction due to the release of myenteric neurotransmitters (Collier et al., 1981; Johnson et al., 1987; David et al., 1993; Mundey et al., 1998) . Furthermore, we have reported that following 20 h incubation of the guinea-pig ileum in morphine at 48C, and subsequent washout to remove the agonist, naloxone was still capable of eliciting a withdrawal contraction (David et al., 1993) , prima facie evidence for the induction of an activated state of mopioid receptors.
The principal aim of this experiment was to compare the ability of structurally diverse m-opioid receptor antagonists, naloxone, CTOP, CTAP and (7)-5,9a-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorphan (MR 2266) (Portoghese et al., 1987; Standifer et al., 1994) , to elicit withdrawal contractions of the guinea-pig isolated ileum in the presence of, and also following prolonged prior exposure to, morphine. These ®ndings were expected to provide greater insight into the pharmacological signi®cance of`inverse agonism' in a physiologically-intact system and shed light on the reported inability of CTAP to precipitate withdrawal symptoms in morphinedependent mice (Bilsky et al., 1996) . During the course of our investigation it also became necessary to (i) optimize the conditions required for prolonged exposure to morphine to induce naloxone-induced contractions, (ii) establish equieective concentrations of the antagonists for inhibition of the acute eects of morphine at m-opioid receptors and (iii) examine the pharmacological signi®cance of`non-opioid' actions of putative antagonists.
Methods
Male Dunkin-Hartley guinea-pigs (500 ± 900 g) were killed by a blow to the head and exsanguination. The ileum was exteriorized, the ileo-caecal junction located and approximately 70 cm removed. A 10 cm segment of the terminal portion was then discarded before the contents of the remaining ileum was¯ushed out with modi®ed KrebsHenseleit solution (previously gassed with 95% O 2 / 5% CO 2 and maintained at 378C). The ileum was then divided into either 5 ± 6 cm segments which were used on the day of the experiment (`fresh') or into 12 ± 15 cm segments which were stored overnight at 48C in a sealed conical¯ask containing 50 ml Krebs-Henseleit solution (`overnight'). For the`overnight' tissues, morphine (0.03, 0.1, 0.3, 1, or 3 mM) was often included in the Krebs-Henseleit solution 1 h after equilibration in the refrigerator and the vessel resealed. Preparations not exposed to morphine overnight were called`overnight, morphine-naive', while those incubated with morphine were considered to be`overnight, morphine-exposed'. The total incubation time with morphine at 48C was 18 ± 22 h. The following day the incubation medium was exchanged for fresh Krebs-Henseleit solution (also maintained at 48C and previously gassed with 95% O 2 /CO 2 ), gently swirled and replaced in the refrigerator. This washout protocol was repeated four times over 60 min and the segments were then left for a further 60 min at room temperature to increase removal of morphine. For the`overnight' preparations, direct exposure to morphine was only conducted at 48C.
For both the`fresh' and`overnight' tissues, 5 ± 6 cm segments were secured to a perspex holder with two parallel platinum wires and then placed in a 20 ml isolated organ bath containing Krebs-Henseleit solution (maintained at 378C and gassed with 95% O 2 /5% CO 2 ). The upper end of the segment was attached by cotton to a Grass FT03C isometric transducer connected to a CED 1902 ampli®er (Cambridge Electronic Devices, Cambridge, U.K.) and, via a 1401 Laboratory interface to a 486 PC running Spike 2 software (CED). After 30 min equilibration, 2 g wt resting tension was applied (which usually declined to approximately 0.5 g wt.). The preparations were stimulated transmurally (0.1 Hz, 0.3 ms, 200 mA; D330-multisystem stimulator, Digitimer Ltd, U.K.) and a minimum of 45 min allowed to establish reproducible responses. All preparations were washed twice with fresh Krebs-Henseleit solution 30 min into the period of electrical stimulation.
Assessment of the eect of naloxone on`fresh' and overnight-stored' preparations For the`fresh' preparations, at the end of the control period of electrical stimulation morphine (0.03, 0.1, 0.3, or 3 mM) was added for a further 60 min. The stimulator was then switched o and 1 mM naloxone added. Once the associated withdrawal contraction had declined to baseline, the stimulator was again turned on for 5 min and ®nally each preparation was exposed to 60 mM KCl. For the`overnight' preparations (`morphinenaive' and`morphine-exposed') a similar protocol was adopted except that morphine was not added to the organ bath. In a separate series of experiments, the eect of morphine on electrically-evoked contractions of`overnight, morphine-naive' and`overnight, morphine-exposed' preparations was determined. Cumulatively increasing concentrations (0.5 log unit) of morphine (0.003 ± 3 mM) were added at intervals of 5 min, or until a plateau had been reached.
m-Opioid receptor antagonists and morphine-induced inhibition of electrically-evoked contractions
After stable electrically-evoked contractions were obtained, fresh' segments were exposed to various concentrations of either naloxone, MR 2266, CTOP or CTOP and 40 min later the eect of cumulatively increasing concentrations of morphine determined. In each experiment the eect of morphine on electrically-evoked contractions was also examined in the absence of the antagonist. Only one concentration response curve to morphine was determined in each preparation. The eect of 20 nM norbinaltorphimine was also determined against morphine-and trans-3,4-dichloro-Nmethyl -N -[2 -(1 -pyrorolidinyl)cyclohexyl] -benzenacetamide methane sulphonate (U50488H)-induced inhibition of the electrically-evoked contractions. In a separate series of experiments the eect of 3 mM CTOP and 0.3 mM MR2266 on electrically-evoked contractions was examined in the presence and absence of either 1 mM somatostatin or 1 mM naloxone. m-Opioid receptor antagonists and withdrawal contractions of`fresh' and`overnight, morphine-exposed' preparations
The eect of equieective concentrations of the antagonists was examined in`fresh' preparations of the guinea-pig ileum in the presence of 0.3 mM morphine and also following overnight exposure to morphine (1 mM).
Data analysis
Electrically-evoked contractions have been expressed as either force (g wt.) or as a percentage of the contraction to 60 mM KCl, while the inhibitory eect of drugs has been calculated as a percentage of the control response. Antagonist-induced contractions have been calculated as a percentage of the contraction caused by 60 mM KCl. All data are shown as the mean+s.e.mean. The potency of the opioid receptor agonists in the absence and presence of the antagonists was assessed as the negative logarithm of the concentration required to cause 50% of the maximum response (pD 2 ) using the logistic equation described by DeLean et al. (1978) with Kaleidagraph software (Synergy) on a Macintosh LC II computer. For the antagonist experiments, the ratio of the concentration of the agonist producing 50% of the maximum response, in the presence and absence of the antagonist, the agonist concentration-ratio, was determined in each experiment. Dierences between mean pD 2 values and the eect of drugs on the electrically-evoked contractions were assessed by a Student ttest with P50.05 considered statistically signi®cant. In many experiments, the withdrawal contractions to the antagonists were variable and, therefore, dierences were assessed by using either a Kruskal Wallis test followed by Dunn's test for individual comparisons or by a Mann-Whitney U-test.
Drugs
The following compounds were used: morphine sulphate (Evans, Speke), (7)-5,9a-diethyl-2-(3-furyl-methyl)-2'-hydroxyl-6,7-benzomorphan (MR 2266; Boehringer Ingelheim KG),
and 
Results
The eect of naloxone on`fresh' and`overnight' preparations of the guinea-pig ileum
As shown in Figure 1a , 3 mM morphine caused a 82.4+6.1% (n=9) reduction of electrically-evoked contractions of`fresh' Figure 1 The eect of morphine and naloxone on the guinea-pig isolated ileum. (a) A graph of electrically-evoked contractions (open columns) in the absence of morphine, the presence of 3 mM morphine and a combination of 3 mM morphine and 1 mM naloxone. Also shown is the withdrawal contraction (closed column) observed upon addition of 1 mM naloxone. Responses have been expressed as a percentage of the contraction to 60 mM KCl and shown as the mean+s.e.mean of nine (electrically-evoked contractions) and eight out of 9 (withdrawal contractions) observations. (b). A representative digitized trace recording of the eect of 1 mM naloxone on`fresh' segments of guinea-pig isolated ileum in the presence (upper, morphine-present) and absence (lower, morphine-naive) of 3 mM morphine.
Note that 1 mM naloxone only produced a withdrawal contraction in the presence of morphine and that this was associated with a reversal of the inhibitory eect exerted by the agonist on electrically-evoked contractions. (c) A graph of electrically-evoked contractions (open columns) of preparations previously exposed to 3 mM morphine overnight (48C), and subsequently washed to remove the agonist, in the absence and presence of 1 mM naloxone. Also shown is the withdrawal contraction (closed column) observed upon addition of 1 mM naloxone. Responses have been expressed as a percentage of the contraction to 60 mM KCl and shown as the mean+s.e.mean of seven (electrically-evoked contractions) and seven out of seven (withdrawal contractions) observations. (d). A representative digitized trace recording of the eect of 1 mM naloxone on segments of the guinea-pig isolated ileum previously stored overnight (48C) in either the presence (upper; morphine-exposed) or absence (lower; morphine-naive) of 3 mM morphine, and subsequently washed repeatedly to remove the agonist. Note that 1 mM naloxone only produced a withdrawal contraction in the preparation previously exposed to morphine, but that this was not associated with a change in the magnitude of the electrically-evoked contractions.
segments of the guinea-pig isolated ileum which was reversed by the addition of 1 mM naloxone. In eight out of nine of these preparations (`fresh, morphine-present') the addition of naloxone was associated with a non-sustained contraction equivalent to 37.5+6.1% (n=8) of the contraction to 60 mM KCl (see Figure 1a ,b). In the absence of morphine (`fresh, morphine-naive') 1 mM naloxone failed to elicit a contraction (n=7; Figure 1b) . In a separate series of experiments, 1 mM naloxone also failed to elicit a withdrawal contraction in the presence of 3 mM morphine if 0.3 mM tetrodotoxin was included in the medium (n=4). Following overnight storage of the ileum at 48C in modi®ed Krebs-Henseleit solution, either with (`overnight, morphineexposed') or without (`overnight, morphine-naive') 3 mM morphine, and subsequent washing with morphine-free Krebs-Henseleit solution, the responses to 60 mM KCl and electrical ®eld stimulation were not signi®cantly dierent from fresh' preparations (Table 1) . As shown in Figure 1c , while 1 mM naloxone did not alter the electrically-evoked contraction of overnight, morphine-exposed preparations, it caused large, non-sustained contractions (Figure 1c,d ) equivalent to 44.6+5.0% of the response to 60 mM KCl (n=7). In overnight, morphine-naive preparations, however, naloxone neither elicited a contraction (Figure 1d ) nor did it aect responses following the resumption of electrical stimulation (n=7). In a separate series of experiments, 1 mM naloxone also failed to elicit a withdrawal contraction of preparations previously exposed to 3 mM morphine if 0.3 mM tetrodotoxin was included in the medium (n=5).
The a-adrenoceptor antagonist phentolamine (1 mM) failed to elicit a contraction of the ileum either in the presence of, or following exposure to, morphine (n=5 for both conditions). However, phentolamine (1 mM) caused a withdrawal contraction (20.6+4.2% of 60 mM KCl, n=11) of the ileum in the presence of 0.1 mM clonidine (60 min exposure), while naloxone (1 mM) was devoid of activity under these conditions (n=5).
As shown in Figure 2 , the magnitude of the naloxoneinduced contractions in`overnight' preparations was dependent upon the concentration of morphine, but the response iǹ fresh' preparations (morphine-present) was largely independent of the concentration of the agonist. The maximum response to naloxone in`fresh' preparations (28.0+5.1%, n=15/17) was obtained in the presence of 0.3 mM morphine, while the maximum response in overnight preparations was observed following exposure to 1 mM morphine (68.9+7.4%, n=5/5). Interestingly, morphine exhibited similar potency as an inhibitor of electrically-evoked contractions in overnight, morphine-naive (max response 68.4+6.3%; pD 2 7.13+0.03, n=8) and overnight morphine-exposed (1 mM) preparations (max response 60.7+5.8%; pD 2 7.23+0.06, n=8) (Figure 3) .
Thus, naloxone produces a contraction of overnight, morphine-exposed (1 mM) preparations despite evidence that the washout procedure had ensured removal of the agonist from the receptor (no change in magnitude of the electrically-evoked contractions following naloxone), and there being no change in the sensitivity of the preparation to morphine. The contractions are shown as the mean+s.e.mean with 'n' indicating the number of experiments conducted. Figure 2 A graph of the relationship between morphine concentration and the magnitude of withdrawal contraction of the guinea-pig isolated ileum elicited by naloxone. Preparations of the guinea-pig ileum were exposed to various concentrations of morphine and then exposed to 1 mM naloxone (`fresh') or stored overnight (48C) in the presence of morphine, washed repeatedly to remove the agonist, and challenged with 1 mM naloxone (overnight-morphine-exposed). Each preparation was exposed to only a single concentration of morphine and naloxone. Responses have been expressed as a percentage of the contractions to 60 mM KCl and shown as the mean+s.e.mean of the preparations that responded to naloxone. The number of experiments conducted are given in parenthesis: fresh, 0.03 mM (17), 0.1 mM (eight), 0.3 mM (17) and 3 mM (nine) morphine; overnight, morphine-exposed, ®ve experiments for each concentration. Figure 3 A comparison of the eect of morphine on electricallyevoked contractions of the guinea-pig isolated ileum following overnight storage (48C) in either the absence (`morphine-naive') or presence of 1 mM morphine (`morphine-exposed') and subsequently washed repeatedly to remove the agonist. The electrically-evoked contractions have been expressed as a percentage of the response prior to the addition of morphine and are shown as the mean+ s.e.mean of eight observations.
Ileal contractions and m-opioid antagonists
The eect of`selective' antagonists against morphine-induced inhibition of neurogenic responses iǹ fresh' preparations of the guinea-pig ileum
As shown in Figure 4 , naloxone (0.01 ± 1 mM), MR-2266 (0.01 ± 1 mM), CTOP (0.3 and 3 mM) and CTAP (0.3 and 3 mM) caused a concentration-dependent, rightward displacement of morphine-induced inhibition of neurogenic contractions, without altering the maximum inhibition. For naloxone, CTAP and CTOP the magnitude of the displacement of the morphine concentration response curve was related to the concentration of the antagonist. For MR-2266, however, the inhibition produced by 0.1 mM MR2266 (morphine pD 2 ± 5.85+0.16, n=5) was only 3 fold greater than that produced by 0.01 mM MR-2266 (morphine pD 2 ± 6.40+0.14, n=5) (see also Figure 4b ). Since MR 2266 also possesses high anity for k-opioid receptors (Miller et al., 1986) , we sought to determine the contribution of this receptor to the action of morphine. Norbinaltorphimine (20 nM), a k-selective opioid receptor antagonist (Portoghese et al., 1987) , failed to aect morphine-induced inhibition of neurogenic contractions (control pD 2 7.51+0.09 (n=5); norbinaltorphmine pD 2 7.45+0.15 (n=5)), but produced a 200 fold rightward displacement of the concentration response curve for U50488H, a k-selective opioid receptor agonist (control pD 2 8.90+0.07 (n=6), norbinaltorphmine pD 2 6.70+0.09 (n=6)). Thus, k-opioid receptors do not make a signi®cant contribution to the eect of morphine in the guinea-pig ileum. Figure 5 shows the Schild plot for the eect of the antagonists on morphine-induced inhibition of neurogenic contractions of the guinea-pig ileum, and indicates that 0.3 mM Figure 4 Comparison of the eect of (a) naloxone, (b) MR 2266, (c) CTOP and (d) CTAP on morphine-induced inhibition of electrically-evoked contractions of the guinea-pig isolated ileum. The electrically-evoked contractions have been expressed as a percentage of the response prior to the addition of morphine and are shown as the mean+s.e.mean of 5 ± 10 observations. Figure 5 Schild plot of the eect of various opioid receptor antagonists on morphine-induced inhibition of electrically-evoked contractions of the guinea-pig isolated ileum. Each log (DR-1) value represents the mean+s.e.mean of 5 ± 10 observations. naloxone, 0.3 mM MR2266, 3 mM CTOP and 3 mM CTAP can be considered equieective concentrations, producing between a 50 ± 100 fold displacement of the agonist concentration response curve. These concentrations of the antagonists were used for the ®nal series of experiments.
During the course of these experiments we noted that a number of the antagonists caused a transient reduction in the electrically-evoked contractions. Figure 6a shows that the addition of 3 mM CTOP produced a signi®cant reduction of neurogenic contractions of the guinea-pig ileum which returned towards control values over the following 5 ± 10 min. As indicated in Table 2 , MR2266 and, to a lesser extent, naloxone produced qualitatively similar eects on neurogenic contractions. In marked contrast, 3 mM CTAP did not signi®cantly aect neurogenic contractions (Table 2) . Since this study involves a comparison of the ability of receptor antagonists to elicit transient biological responses, it was considered necessary to determine the basis of the inhibitory eect of CTOP and MR2266.
Somatostatin (1 mM), the endogenous peptide upon which CTAP and CTOP are based (Hawkins et al., 1989; Kramer et al., 1989) , also caused a signi®cant, short-lived inhibition of neurogenic responses (Figure 6b ) and signi®cantly reduced the inhibitory eect of 3 mM CTOP (Table 2; Figure 6c ). In contrast, the inhibitory eect of MR 2266 and CTOP were not altered by the presence of naloxone (Table 2) . Thus, the antagonists MR 2266 and CTOP possess transient, inhibitory activity in the guinea-pig ileum that appears to involve a naloxone-insensitive mechanism. In the case of CTOP this eect may be mediated via somatostatin receptors.
Comparison of the antagonists in fresh and overnight, morphine-exposed ileal segments Figure 7a shows that equieective concentrations of naloxone, MR 2266, CTOP and CTAP produced a contraction of fresh segments of the ileum in the presence of 0.3 mM morphine. In each instance the contractions were not sustained but lasted 3 ± 5 min. For CTOP (3 mM), only four of the eight preparations examined responded with a contraction and the mean response was signi®cantly less (P50.05) than that produced by CTAP (eight out of eight preparations). In the four`CTOP-unresponsive' preparations the displacement of the agonist from the receptor was indicated by reversal of the eect of morphine on electrically-evoked contractions; an eect also observed in the four`CTOP-responsive' preparations and those exposed to CTAP. Figure 7b shows that the antagonists also produced contractions of overnight, morphine-exposed preparations but the response to 3 mM CTOP (36.1+6.1% of 60 mM KCl, n=12) and 0.3 mM MR 2266 (35.9+7.2% of 60 mM KCl, n=12) were signi®cantly smaller than that elicited by 3 mM CTAP (69.7+7.2% of 60 mM KCl, n=12). In each instance the magnitude of the electrically-evoked contractions was not signi®cantly altered by the antagonist. Naloxone (0.3 mM) produced similar responses to 3 mM CTAP, both in the presence of, and following exposure to, morphine (Figure 7) . Figure 6 Representative digitized recordings of the eect of (a) 3 mM CTOP, (b) 1 mM somatostatin (SS) and (c) 3 mM CTOP in the presence of 1 mM somatostatin (stippled bar), on electrically-evoked contractions of the guinea-pig isolated ileum. Note that CTOP and somatostatin caused a transient inhibition of electrically-evoked contractions but that CTOP failed to do in the presence of somatostatin. The`initial' response was measured as the peak eect following addition of the antagonist, while the`®nal' response is that measured after 10 min incubation. Responses to electrical ®eld stimulation have been expressed as a percentage of the response prior to the addition of the agent under investigation and are shown as the mean+s.e.mean of 5 ± 10 observations, unless indicated otherwise. *denotes a statistically signi®cant dierence (P50.05) from the corresponding value under control conditions (Student's t-test). n.a. denotes not applicable.
Ileal contractions and m-opioid antagonists Figure 8 shows that the presence of 1 mM somatostatin (added 20 min before the antagonists but after 0.3 mM morphine) signi®cantly reduced naloxone-induced contractions but failed to aect those elicited by 3 mM CTOP.
Discussion
Pharmacological characteristics of antagonist-induced contractions following exposure to morphine
We have con®rmed our earlier observation that overnight exposure of the guinea-pig isolated ileum to morphine (at 48C), followed by extensive washing to remove the agonist, induces à state' of m-opioid receptors that renders naloxone capable of producing neurogenic contractions (David et al., 1993) . Qualitatively, this ®nding is similar to that reported for naloxone on both adenylyl cyclase activity and cyclic AMP formation in SH-SY5Y cells previously exposed (48 h at 378C) to morphine (Wang et al., 1994) , and raises the possibility that a common mechanism may account for antagonist-induced responses in both systems. In addition, we have established that the response to naloxone is comparable in both magnitude and origin to`withdrawal contractions' of the guinea-pig ileum elicited by naloxone in the presence of morphine (Collier et al., 1981; Mundey et al., 1998) and, as evidenced by the lack of eect of phentolamine, speci®c for opioid receptors.
The appearance of naloxone-induced contractions in the presence of, and following exposure to, morphine raises the possibility that the latter response simply arises from the presence of residual morphine due to inadequate washing. Several observations argue against this explanation. Firstly, the magnitude of the electrically-evoked contractions (and also that to KCl) was not altered by overnight exposure to morphine. Secondly, neither the sensitivity of the electricallyevoked contractions to inhibition by morphine nor the maximum eect produced were in¯uenced by the experimental manipulation. These observations also provide evidence against the development of tolerance in the myenteric plexus to the eect of morphine (see David et al., 1993) . Thirdly, and perhaps most revealing, is that while naloxone-induced contractions in the presence of morphine were associated with a reversal of the action of the agonist on electrically-evoked contractions, this was not the case in preparations previously exposed overnight to morphine (see Figure 1) . It would appear, therefore, that prior to the addition of naloxone, morphine was either absent or present at a concentration below which any signi®cant eect on electrically-evoked contractions could be detected (510 nM). Interestingly, the conclusion regarding the relationship between naloxone-induced responses and agonist concentration is similar to that advanced by Kishioki et al. (1995) in morphine-dependent rats. It was noted that withdrawal symptoms precipitated by naloxone in this model were as pronounced at 24 h after the last dose of morphine (when plasma morphine was only 1% of steady state levels) as that observed 12 h earlier.
Clearly there are obvious parallels between our observations of antagonist-induced responses in the absence of an agonist and those reported for other receptors (e.g., Costa & Herz, 1989; Chidac et al., 1996; Jansson et al., 1998) . However, the term`constitutively-active' has not been used to describe the m-opioid receptor in the ileum since the state of the receptor under examination is not an inherent characteristic of the tissue, but a consequence of prolonged pre-treatment with an agonist. This stands in marked contrast to that reported recently for m-opioid receptors expressed on HEK-293 cells, for example, which exhibits elevated signalling activity under basal conditions (Burford et al., 2000) .
Although the myenteric plexus of the guinea-pig isolated ileum is endowed with m and k opioid receptors (Dhawan et al., 1996) , the available evidence suggests that only the m-opioid subtype is involved in responses elicited by antagonists. All four antagonists caused concentration-dependent inhibition of morphine-induced inhibition of electrically-evoked contractions. In the case of CTOP and CTAP, the potency (estimated pK B ± 7.5) was similar to that reported for interaction with mopioid receptors in the guinea-pig ileum (Wire et al., 1987; Tonini et al., 1998) . Similarly, while MR 2266 possesses slightly higher anity for k opioid receptors than for m-opioid receptors (Miller et al., 1986; Portoghese et al., 1987) the potency (estimated pK B ± 8.5) is consistent with an eect at the latter subtype. Also, norbinaltorphimine, a selective k-opioid receptor blocker (Dhawan et al., 1996) , inhibited responses to U50488H, a selective k-opioid receptor agonist, but failed to alter morphine-induced inhibition of electrically-evoked contractions. Hence, it is unlikely that k-opioid receptors are involved in mediating the eect of morphine and, therefore, the subsequent antagonist-induced contractions.
Equieective concentrations of the antagonists were chosen in order to assess their ability to evoke contractions of the ileum following overnight exposure to, and in the presence of, morphine. This condition was deemed crucial to the objectives of the experiment, since we were particularly interested in establishing whether any of the agents behaved as a neutral antagonist, i.e. devoid of constrictor activity in either circumstance. Each antagonist was found to elicit contractions in both the presence of, and following exposure to, morphine, but those to CTOP were signi®cantly smaller than those produced by CTAP. Following overnight exposure to morphine further signi®cant dierences between the antagonists were revealed, with both CTAP and naloxone producing larger responses than equieective concentrations of CTOP or MR-2266. While these observations could be taken as preliminary evidence for CTOP and MR-2266 possessing weaker`inverse agonist' properties at the agonist-free, activated m-opioid receptor, the pharmacological pro®le of this eect is dierent from that described by Wang et al. (1994) . In particular, both CTAP and CTOP were considered to act as neutral antagonists in SH-SY5Y cells, capable of antagonising the opposing eects of morphine and naloxone on cyclic AMP formation, yet in the ileum CTAP produced contractions as large as those elicited by naloxone.
Our ®nding that CTAP and naloxone produced quantitatively similar eects in the ileum is consistent with work by Maldonado et al. (1992) who demonstrated that both agents precipitated withdrawal symptoms in morphine-dependent rats. Although these results are at odds with those of Bilsky et al. (1996) , in which CTAP failed to precipitate withdrawal symptoms in morphine-dependent mice, it is noteworthy that Maldonado et al. (1992) employed a 1000 fold dose range for the antagonist to ensure detection of responses. Similarly our experiments were designed on the basis of establishing equieective concentrations of the antagonists prior to assessing their potential to elicit contractions During the course of our experiments it became evident that both CTOP and MR-2266 caused a transient inhibition of the electrically-evoked contractions. In light of the report that CTOP (but not CTAP) possesses agonist activity at somatostatin receptors (Connor et al., 1997a) , and that these receptors are present in the ileum (Fenuik et al., 1995) , we investigated whether co-activation of a non-opioid receptor could account for the reduced responses to CTOP in overnight, morphine-exposed preparations of the ileum. Our results showed that somatostatin produced qualitatively similar responses to CTOP and that subsequent desensitization of the receptor reduced the eect of CTOP on electrically-evoked contractions. Moreover, in the presence of morphine somatostatin signi®cantly reduced naloxone-induced contractions but failed to alter responses elicited by CTOP. It is noteworthy that Connor et al. (1997b) have reported the presence of somatostatin receptors (sst 2 ) on SH-SY5Y cells, which raises the possibility that an action on this receptor subtype contributed to the apparent neutral antagonist activity of CTOP in these cells (Wang et al., 1994) . Although the basis of the non-opioid eect of MR-2266 was not examined in detail, it seems likely that the responses in overnight, morphine-exposed preparations was attenuated by this factor. Taken together, these observations indicate that caution is required when interpreting the action of putative inverse agonists in physiologically-intact systems, particularly in the absence of a neutral antagonist.
Thus, while we have provided convincing evidence that structurally dissimilar m-opioid receptor antagonists can elicit neurogenic contractions of the guinea-pig ileum in the absence of an agonist, none of the data supports the view that the range of activity observed re¯ects intrinsic dierences in their ecacy as`inverse agonists'. Crucially, we were unable to identify an agent devoid of this activity (a neutral antagonist) which could provide unequivocal, pharmacological evidence that antagonist-induced responses are mediated via m-opioid receptors. Also, it remains unclear whether a neutral antagonist may have reduced propensity to precipitate withdrawal symptoms in morphine-dependent rats, as has been suggested by Bilsky et al. (1996) .
Cellular events associated with antagonist-induced contractions following exposure to morphine
The ability of prolonged exposure to morphine to alter the basal state of m-opioid receptors in the guinea-pig myenteric plexus is similar to that reported for isoprenaline at b 2 -adrenoceptors in Sf9 cells (Chidac et al., 1996) . In this instance, a reduction in adenylyl cyclase activity was noted following exposure to isoprenaline, and the weak partial agonist dichloroisoprenaline acted as an inverse agonist at b 2 -adrenoceptors, i.e. to elicit a reduction in basal adenylyl cyclase activity. Modulation of adenylyl cyclase activity and cyclic AMP has long been a major focus of attention for groups investigating subcellular mechanisms underlying opiate tolerance and dependence (see Nestler 1992) . For example, chronic activation of m-opioid receptors has been reported to elevate basal adenylyl cyclase activity in CHO cells transfected with m-opioid receptor (Avidor-Reiss et al., 1995) , SY-SH5Y cells (Ammer & Schulz, 1993; Wang et al., 1994) , A431 cells (Ammer & Schultz, 1997) and even in the guinea-pig longitudinal muscle myenteric plexus preparation (Chakrabarti et al., 1998) . However, with the exception of the observations by Wang et al. (1994) , none of the above studies have shown that the alteration in basal adenylyl cyclase is accompanied by qualitative changes in the biological activity of m-opioid receptor antagonists. Moreover, the signi®cance to our study of any sustained alteration in enzyme activity by an agonist remains unclear for two reasons. First, it is not known whether similar changes occur when the ileum is exposed overnight to morphine at 48C. Second, m-opioid responsive neurones in the myenteric plexus (S neurones) are not aected by agents that elevate cyclic AMP levels (Nemeth et al., 1986; Johnson & Pillai, 1990) .
In summary, we have demonstrated that overnight exposure of the guinea-pig isolated ileum to morphine induces changes in myenteric m-opioid receptors, qualitatively similar to those reported in SH-SY5Y and HEK 293 cells (Wang et al., 1994; 1999) , that permit antagonists to elicit a biological response in the absence of an agonist. While dierences between the antagonists were noted, it seems likely these are a consequence of non-opioid actions rather than evidence for partial inverse agonism at a constitutively-activated receptor.
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